Antengene Expands XPOVIO® Approval in Malaysia to Relapsed or Refractory DLBCL

Antengene Corporation Limited, a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing fir...

December 18, 2025 | Thursday | News
Norgine Secures Exclusive Rights to Vir Biotechnology’s Hepatitis Delta Combination Therapy

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceutical...

December 18, 2025 | Thursday | News
Minghui Pharma Secures FDA IND Clearance to Launch Global Phase 3 Trials of MHB018A in Thyroid Eye Disease

Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announc...

December 16, 2025 | Tuesday | News
Vaxxas Gains Regulatory Green Light to Manufacture HD-MAP for Clinical Trials

Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted a licence by the Therapeutic Goods Administration (TGA) to manufacture the Company&rsqu...

December 16, 2025 | Tuesday | News
Eurofins Expands Consumer Product Testing Footprint with Major New Facility in Vietnam

Eurofins Consumer Product Testing Vietnam has completed a major expansion, seeing the laboratory move to a purpose-built 7,000 sq. m laboratory in Ho Chi...

December 11, 2025 | Thursday | News
GlycoNex Enters CDMO Agreement to Advance First-in-Class Anti-HMGB1 Antibody Into Clinical Trials in Japan

Collaboration with Science Tokyo spinout underscores GlycoNex's integrated antibody development and manufacturing capabilities in support of first-in-cla...

December 09, 2025 | Tuesday | News
Daniella Cramp Emphasizes Asia’s Growing Role in Global Biopharma as Thermo Fisher Expands Network in Korea Singapore and India

    “Asia continues to play an increasingly important role in advancing innovation across the global biopharma industry,” said Dani...

December 04, 2025 | Thursday | News
Eisai and Biogen Submit Subcutaneous Lecanemab (LEQEMBI®) Application to Japan’s PMDA

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachuse...

December 01, 2025 | Monday | News
SK Biopharmaceuticals Deepens Radiopharma Strategy With Exclusive License to WT-7695 From WARF

  New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partne...

November 28, 2025 | Friday | News
Sanyou Bio and FatiAbGen Forge Strategic Alliance to Accelerate Global Antibody Discovery

  Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a compre...

November 28, 2025 | Friday | News
Celltrion Secures EU Green Light for Omlyclo™ 300 mg PFS, Enhancing Biosimilar Options for Allergic Diseases

  Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) p...

November 28, 2025 | Friday | News
Galux Demonstrates Precision AI Platform That Delivers Drug-Grade Antibodies in Weeks

-Galux, a South Korean biotech pioneering AI-driven protein therapeutics design, announced new experimental findings demonstrating that its AI protein de...

November 27, 2025 | Thursday | News
Nxera Realigns Strategic Priorities to Advance Next-Generation GPCR Medicines and AI-Enabled Discovery

Nxera Pharma Co., Ltd. announced a focused restructuring designed to concentrate investment and resources on efficient platforms, programs and products w...

November 18, 2025 | Tuesday | News
Angelini Ventures Expands to Asia with Singapore Hub to Power Biotech and Healthtech Innovation

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelin...

November 14, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close